Invited Commentary

Current Oncology Reports

, Volume 14, Issue 6, pp 483-485

First online:

Progression-Free Survival Versus Overall Survival in Ovarian Cancer: Where Are We Now?

  • Susana BanerjeeAffiliated withGynaecology Unit, The Royal Marsden NHS Foundation Trust
  • , Stan KayeAffiliated withDivision of Clinical Studies, Institute of Cancer Research Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Ovarian cancer Poly(adenosine diphosphate ribose) polymerase inhibitors Survival End point Olaparib Bevacizumab